NSE ScannerOpen the scanner

Medical Devices & Supplies · Medical Specialties · NSE: AVIENCE · data 2026-10-30

Avience Biomedicals Limited

₹253.15-4.45% on 30 OctHealth: Strong 7.1/10
Jun 2026Low ₹222.85 · High ₹414.95-39.0%

In plain words

Price: 39.0% below its 52-week high of ₹414.95.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price
₹253.15
Market cap
₹145 cr
P/E
11.7
P/B
3.3
ROE
32.4%
ROCE
35.9%
Debt / equity
0.92
Dividend yield
0.00%
1-year return
-35.9%
52-week high
₹414.95
52-week low
₹222
Operating margin
26.1%

Growth

Revenue (last 12 months)₹53 cr
Net profit (last 12 months)₹9 cr
Sales growth, 3 years (yearly)68.8%
Profit growth, 3 years (yearly)123.6%

Smart-money activity

5/100 · Weak over the last ~60 sessions

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Common questions

Is Avience Biomedicals Limited debt-free?

Its latest reported debt-to-equity ratio is 0.92.

What is Avience Biomedicals Limited's P/E ratio?

About 11.7, based on the last 12 months' earnings and a price of ₹253.15 (data 2026-10-30).

What is the 52-week high and low of Avience Biomedicals Limited?

The 52-week high is ₹414.95 and the 52-week low is ₹222.

Similar companies

Osel Devices Limited (OSELDEVICE) · Yash Optics and Lens Limited (YASHOPTICS) · Nureca Ltd. (NURECA) · Mohini Health & Hygiene Ltd. (MHHL) · Gkb Ophthalmics Limited (GKB)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open AVIENCE in NSE Scanner →
Share on WhatsAppShare on Telegram